Glaukos Corporation
GKOS Healthcare Medical Devices
Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024.
- Revenue
- +58.0%
- EPS
- +110.7%
- Free cash flow
- +411.2%
- Total debt
- −2.25%
Quarter to September 2026, against a year earlier
Follow GKOS
Alert me
Glaukos Corporation (GKOS) Book value per share
Glaukos Corporation's book value per share at the end of fiscal 2025 was 11.5×, down 21.1% from 14.5× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 12.1×. Over the past ten years it has ranged from 3.6× (fiscal 2016) to 18.0× (fiscal 2019); the current reading is higher than 64% of that period. Glaukos Corporation ranks 31st of 149 Medical Devices companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 11.5× | (21.08%) |
| FY2024 | 14.5× | 52.48% |
| FY2023 | 9.5× | (14.65%) |
| FY2022 | 11.2× | (11.67%) |
| FY2021 | 12.6× | (15.68%) |
| FY2020 | 15.0× | (16.78%) |
| FY2019 | 18.0× | 266.12% |
| FY2018 | 4.9× | 22.47% |
| FY2017 | 4.0× | 12.87% |
| FY2016 | 3.6× | (34.62%) |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 12.1× | 4.59% |
| Jun 2026 | 11.6× | 0.35% |
| Mar 2026 | 11.6× | 0.79% |
| Dec 2025 | 11.5× | (14.42%) |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| BIO.B Bio-Rad Laboratories, Inc. compare | 284× |
| BIO Bio-Rad Laboratories, Inc. compare | 284× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 66.8× |
| PEN Penumbra, Inc. compare | 40.2× |
| GMED Globus Medical, Inc. compare | 35.8× |
| PODD Insulet Corporation compare | 22.8× |
| BRKR Bruker Corporation compare | 15.1× |
| GKOS Glaukos Corporation | 12.1× |
| SNN Smith & Nephew SNATS, Inc. compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on GKOS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement